Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula
A Pilot Study Evaluating the Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula
Sponsor: 3M
Terminated
Slow enrollment of patients
This NA trial investigates Ostomy and is currently terminated or withdrawn. 3M leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Dec 2024 — Present [monthly]
Terminated NA
-
Sep 2024 — Dec 2024 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jul 2019 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Jul 2019 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- 3M
- Solventum US LLC
For direct contact, visit the study record on ClinicalTrials.gov .